102
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Prevalence of Sleep Disorders in People with Type 2 Diabetes and Obesity in Saudi Arabia: A Cross-Sectional Study

, , , ORCID Icon, , & ORCID Icon show all
Pages 2075-2083 | Received 21 Dec 2023, Accepted 13 May 2024, Published online: 20 May 2024

References

  • Cho JW, Duffy JF. Sleep, sleep disorders, and sexual dysfunction. World J Mens Health. 2019;37(3):261–275. doi:10.5534/wjmh.180045
  • Voinescu BI, Szentagotai-Tatar A. Sleep hygiene awareness: its relation to sleep quality and diurnal preference. J Mol Psychiatry. 2015;3(1):1. doi:10.1186/s40303-015-0008-2
  • Nam S, Whittemore R, Jung S, Latkin C, Kershaw T, Redeker NS. Physical neighborhood and social environment, beliefs about sleep, sleep hygiene behaviors, and sleep quality among African Americans. Sleep Health. 2018;4(3):258–264. doi:10.1016/j.sleh.2018.03.002
  • Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Bixler EO. Insomnia with objective short sleep duration is associated with type 2 diabetes: a population-based study. Diabetes Care. 2009;32(11):1980–1985. doi:10.2337/dc09-0284
  • Hashimoto Y, Sakai R, Ikeda K, Fukui M. Association between sleep disorder and quality of life in patients with type 2 diabetes: a cross-sectional study. BMC Endocr Disord. 2020;20(1):98. doi:10.1186/s12902-020-00579-4
  • Kalra S, Khandelwal D, Dutta D, Chittawar S. Sleep disorders in type 2 diabetes. Indian J Endocrinol Metab. 2017;21(5):758. doi:10.4103/ijem.ijem_156_17
  • Narisawa H, Komada Y, Miwa T, et al. Prevalence, symptomatic features, and factors associated with sleep disturbance/insomnia in Japanese patients with type-2 diabetes. Neuropsychiatr Dis Treat. 2017;13:1873–1880. doi:10.2147/NDT.S134814
  • Bahnasy WS, El-Heneedy YAE, El-Seidy EAS, Labib NAA, Ibrahim ISE. Sleep disturbances in diabetic peripheral neuropathy patients: a clinical and polysomnographic study. Egypt J Neurol Psychiatr Neurosurg. 2018;54(1):23. doi:10.1186/s41983-018-0024-0
  • Keskin A, Ünalacak M, Bilge U, et al. Effects of sleep disorders on hemoglobin A1c levels in type 2 diabetic patients. Chin Med J. 2015;128(24):3292–3297. doi:10.4103/0366-6999.171415
  • Verma S, Hussain ME. Obesity and diabetes: an update. Diabetes Metab Syndr. 2017;11(1):73–79. doi:10.1016/j.dsx.2016.06.017
  • Hu Y, Bhupathiraju SN, de Koning L, Hu FB. Duration of obesity and overweight and risk of type 2 diabetes among US women. Obesity. 2014;22(10):2267–2273. doi:10.1002/oby.20851
  • Kleinert M, Clemmensen C, Hofmann SM, et al. Animal models of obesity and diabetes mellitus. Nat Rev Endocrinol. 2018;14(3):140–162. doi:10.1038/nrendo.2017.161
  • Antza C, Kostopoulos G, Mostafa S, Nirantharakumar K, Tahrani A. The links between sleep duration, obesity and type 2 diabetes mellitus. J Endocrinol. 2022;252(2):125–141. doi:10.1530/JOE-21-0155
  • McNeil J, Doucet É, Chaput JP. Inadequate sleep as a contributor to obesity and type 2 diabetes. Can J Diabetes. 2013;37(2):103–108. doi:10.1016/j.jcjd.2013.02.060
  • Tan X, Chapman CD, Cedernaes J, Benedict C. Association between long sleep duration and increased risk of obesity and type 2 diabetes: a review of possible mechanisms. Sleep Med Rev. 2018;40:127–134. doi:10.1016/j.smrv.2017.11.001
  • Alamer WM, Qutub RM, Alsaloumi EA, Natto NK, Alshehri RM, Khafagy A. Prevalence of sleep disorders among patients with type 2 diabetes mellitus in Makkah City: a cross-sectional study. Cureus. 2022;14(12):e33088. doi:10.7759/cureus.33088
  • Kazem MA. Measuring sleep disorders in the students of the preparatory stage. Basic Educ Coll Magazine Educ Human Sci. 2014;15:272–305.
  • American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2020. Diabetes Care. 2020;43:14–31. doi:10.2337/dc20-S002
  • WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–163. doi:10.1016/S0140-6736(03)15268-3
  • Liu W, Zhang R, Tan A, et al. Long sleep duration predicts a higher risk of obesity in adults: a meta-analysis of prospective cohort studies. J Public Health. 2018;41(2):158–168. doi:10.1093/pubmed/fdy135
  • Shan Z, Ma H, Xie M, et al. Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2015;38(3):529–537. doi:10.2337/dc14-2073
  • Wu Y, Zhai L, Zhang D. Sleep duration and obesity among adults: a meta-analysis of prospective studies. Sleep Med. 2014;15(12):1456–1462. doi:10.1016/j.sleep.2014.07.018
  • Yadav D, Cho K-H. Total sleep duration and risk of type 2 diabetes: evidence-based on clinical and epidemiological studies. Curr Drug Metab. 2018;19(12):979–985. doi:10.2174/1389200219666180628170431
  • Lane JM, Liang J, Vlasac I, et al. Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits. Nat Genet. 2016;49(2):274–281. doi:10.1038/ng.3749
  • Foster GD, Sanders MH, Millman R, et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care. 2009;32(6):1017–1019. doi:10.2337/dc08-1776
  • Shaw JE, Punjabi NM, Wilding JP, Alberti KG, Zimmet PZ. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabet Res Clin Pract. 2008;81(1):2–12. doi:10.1016/j.diabres.2008.04.025
  • Jehan S, Myers AK, Zizi F, Pandi-Perumal SR, Jean-Louis G, McFarlane SI. Obesity, obstructive sleep apnea and type 2 diabetes mellitus: epidemiology and pathophysiologic insights. Sleep Med Disord. 2018;2(3):52–58. doi:10.15406/smdij.2018.02.00045
  • Nedeltcheva AV, Scheer FAJL. Metabolic effects of sleep disruption, links to obesity and diabetes. Curr Opin Endocrinol Diabetes Obes. 2014;21(4):293–298. doi:10.1097/med.0000000000000082
  • Seetho IW, Wilding JPH. Screening for obstructive sleep apnoea in obesity and diabetes – potential for future approaches. Eur J Clin Invest. 2013;43(6):640–655. doi:10.1111/eci.12083
  • Gupta S, Wang Z. Predictors of sleep disorders among patients with type 2 diabetes mellitus. Diabetes Metab Syndr. 2016;10(4):213–220. doi:10.1016/j.dsx.2016.06.009
  • Darraj A, Mahfouz MS, Alsabaani A, Sani M, Alameer A. Assessment of sleep quality and its predictors among patients with diabetes in Jazan, Saudi Arabia. Diabetes Metab Syndr Obes. 2018;11:523–531. doi:10.2147/DMSO.S178674
  • Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev. 2005;9(1):11–24. doi:10.1016/j.smrv.2004.08.001
  • Salín-Pascual RJ, Ortega-Soto H, Huerto-Delgadillo L, Camacho-Arroyo I, Roldán-Roldán G, Tamarkin L. The effect of total sleep deprivation on plasma melatonin and cortisol in healthy human volunteers. Sleep. 1988;11(4):362–369. doi:10.1093/sleep/11.4.362
  • Sanghani NB, Parchwani DN, Palandurkar KM, Shah AM, Dhanani JV. Impact of lifestyle modification on glycemic control in patients with type 2 diabetes mellitus. Indian J Endocrinol Metab. 2013;17(6):1030–1039. doi:10.4103/2230-8210.122618
  • Yoo JS, Lee SJ, Lee HC, Kim MJ. The effect of a comprehensive lifestyle modification program on glycemic control and body composition in patients with type 2 diabetes. Asian Nurs Res. 2007;1(2):106–115. doi:10.1016/S1976-1317(08)60013-4
  • Tuomilehto HP, Seppä JM, Partinen MM, et al. Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea. Am J Respir Crit Care Med. 2009;179(4):320–327. doi:10.1164/rccm.200805-669oc
  • Hippisley-Cox J, Coupland C. Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care. BMJ. 2016;354:i3477. doi:10.1136/bmj.i3477
  • McVeigh GE, Gibson W, Hamilton PK. Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease. Diabetes Obes Metab. 2013;15(3):198–203. doi:10.1111/dom.12013
  • Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–2222. doi:10.1016/S0140-6736(10)60484-9